Plasma-Lyte 148 - SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE
Navigation: NDC > Supplier starting with: B > BAXTER HEALTHCARE CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0338-0179 |
| Proprietary Name: | Plasma-Lyte 148 |
| Suffix: | |
| Non-Proprietary Name: | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 02-02-1979 |
| Category Name: | NDA |
| Application Number: | NDA017378 |
| Labeler: | BAXTER HEALTHCARE CORPORATION |
| Substance Name: | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE |
| Active Numerator Strength: | 30; 37; 368; 526; 502 |
| Active Ingredient Unit: | mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharm Classes: | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |
| DEA Schedule: |